Slovak pharmaceutical industry sees revenue drop in Q1
…almost €2.5bn in Q1, up by 17% year on year, but companies operating in the pharmaceutical sector saw a 4% revenue decline. The revenue drop in the pharma segment can be associated with the ban on the re-export of medicinal products abroad, the association said, as cited by SITA.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)